Old Web
English
Sign In
Acemap
>
authorDetail
>
R. Heinig
R. Heinig
Bayer HealthCare Pharmaceuticals
Pharmacodynamics
Pharmacology
Immunology
Gastroenterology
Progressive disease
2
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I study of BAY 73–4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced solid tumors: Final results of a dose-escalation study
2008
Journal of Clinical Oncology
Annette Frost
Martin Buechert
Clemens Unger
Olaf Christensen
A. Wagner
R. Heinig
M. E. Scheulen
Dirk Strumberg
Ulrike Fasol
K. Mross
Show All
Source
Cite
Save
Citations (6)
Phase I trial of BAY 73-4506, a kinase inhibitor that targets oncogenic and angiogenic kinases, in patients with advanced solid tumors
2007
Molecular Cancer Therapeutics
A. Frost
S. Hedbom
S. Steinbild
Martin Büchert
C. Unger
Olaf Christensen
D. Voliotis
R. Heinig
K. Mross
Show All
Source
Cite
Save
Citations (1)
1